
March 28, 2023
Aura Energy Limited (ASX: AEE, AIM: AURA, “Aura” or “the Company”) will host an investor webinar on March 30 at 10:00 am WST / 1:00 pm AEDT.
KEY POINTS:
- Aura Energy will conduct an investor webinar on March 30 to update investors on the Company’s plans following the announcement of the Enhanced Feasibility Study
- Aura Energy Managing Director, David Woodall, will present an update on the Company’s activities, after which investors will be invited to ask questions.
Aura Energy’s Managing Director, David Woodall, will deliver a presentation to investors outlining the Company’s recent Enhanced Feasibility Study that saw an increase in the Net Present Value of the Tiris Project from AUD$80 million to AUD$226 million.
Mr Woodall will also outline the current market dynamics for uranium and why global efforts to decarbonise are increasing the understanding of the benefits of nuclear power.
Please see the webinar registration details below.
Event: Aura Energy Ltd Investor Webinar
Date/Time: March 30 at 10:00 am AWST / 1:00 pm AEDT
Presenting: Managing Director, David Woodall
Please register for this event using this link: https://ccmediaframe.com/?id=88K2uC1N
Investors will be invited to submit questions via the Q&A function within the webinar platform.
This ASX Release is authorised by the Aura Energy Board of Directors.
Click here for the full ASX Release
This article includes content from Aura Energy, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
AEE:AU
The Conversation (0)
02 June 2023
Aura Energy
Fast-tracking the Tiris Uranium Project to support a clean, decarbonized future
Fast-tracking the Tiris Uranium Project to support a clean, decarbonized future Keep Reading...
02 February
Eagle Energy Metals Corp. and Spring Valley Acquisition Corp. II Announce Effectiveness of Registration Statement and Record and Meeting Dates for Extraordinary General Meeting of Shareholders to Approve Proposed Business Combination
Eagle, a next-generation nuclear energy company with rights to the largest open pit-constrained measured and indicated uranium deposit in the United States, and SVII, a special purpose acquisition company, today announced that the SEC has declared effective the Registration Statement, which... Keep Reading...
30 January
Spot Uranium Passes US$100, Extends Year-Long Rally
Uranium prices surged back above US$100 a pound this week, extending a year-long rally that is reshaping the uranium market after more than a decade of underinvestment.Spot price of uranium climbed US$7.75 to US$101 a pound after the Sprott Physical Uranium Trust... Keep Reading...
29 January
Quarterly Activities/Appendix 5B Cash Flow Report
Basin Energy (BSN:AU) has announced Quarterly Activities/Appendix 5B Cash Flow ReportDownload the PDF here. Keep Reading...
29 January
Quarterly Appendix 5B Cash Flow Report
Basin Energy (BSN:AU) has announced Quarterly Appendix 5B Cash Flow ReportDownload the PDF here. Keep Reading...
27 January
Basin Energy Eyes Uranium Growth in Europe After Sweden Policy Shift
Basin Energy (ASX:BSN) is positioning for growth following Sweden’s significant shift in uranium policy, a move the company’s managing director, Pete Moorhouse, says has major implications not only for the company, but also for Europe’s broader energy strategy. In an interview with the Investing... Keep Reading...
27 January
American Uranium Exec Outlines Lo Herma ISR Progress, Resource Update
American Uranium (ASX:AMU,OTCID:AMUIF) Executive Director Bruce Lane says recent test work at the company’s Lo Herma uranium project in Wyoming has delivered an important proof of concept for its in situ recovery (ISR) development plans. The testing focused on validating aquifer performance, a... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00





